Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiac Pathways was a medical technology company specializing in the diagnosis and treatment of cardiac tachyarrhythmias. The company developed the Chilli Cooled Ablation System and the Realtime Position Management (RPM) system, which allowed for precise, non-fluoroscopic mapping and ablation of heart tissue. These technologies were specifically designed to address complex arrhythmias such as atrial fibrillation and ventricular tachycardia. The Chilli system utilized internal cooling to allow for deeper lesions while minimizing surface tissue damage. In 2001, the company was acquired by Boston Scientific for approximately $115 million, integrating its electrophysiology products into Boston Scientific's broader cardiovascular portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiac Pathways.